(Date:12/2/2009)...INGTON, Va., Dec. 2 From more than...ive us meaning, joy and peace, the LIFE Foundation...t conducted using the popular photo-sharing Web si... a video montage on the LIFE Foundation,s Web site...ntestants submitted one photo and a caption to Fli...
(Date:12/2/2009)...STOWN, N.J., Dec. 2 Wats...unced that the Federal Trade Commission (FTC) has ...nt relating to Watson,s pending acquisition of pri...ination of the Hart Scott Rodino waiting period, t...tion. The parties have now obtained all regulator...
(Date:12/2/2009)...Advisory for Thursday, Dec. 3 ,, Head of Army... Meeting of Army Wounded Warriors; Army Embraces R... ,, WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ ...l Organization on Disability: ,, WHAT: Wounde...nded Warrior (AW2) program,s National Organization...
(Date:12/2/2009)...NGTON and REDMOND, Wash., Dec. 2 /PRNewswire/ -... companies will collaborate to give caregivers sin...tion necessary for providing ongoing care after pa... their families better tools for managing patients...ute care organization to adopt Microsoft Amalga Un...
(Date:12/2/2009)...STOWN, N.J., Dec. 2 Wats...unced that it has completed the acquisition of Arr...purchase creates a financially strong, global spec...in annual revenues and operations in more than 20 ...enefits to Watson shareholders as a result of this...
Breaking Medicine News(10 mins):Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 3Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 4Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5...ivileged "niches" within the bone marrow is helpin...uld protect healthy blood-forming stem cells and i... for leukemia and other types of cancer. , In a ...one of the chemical signals that leukemic cells re...
...d drug for men suffering from a painful pelvic con...mptoms in an international study led by Queen,s Un...al Hospital, Curtis Nickel. , The drug, called Al...imated to affect from six to 12 per cent of the po...
...groups say good glycemic control still best course... While less strict blood sugar control may be appr...here to the target goal of less than 7 percent tha... the American Diabetes Association, the American C...
... panic attacks or panic disorder have a greater ri...fering a heart attack than the normal population, ...ording to research published in Europe,s leading c...diagnosed had a significantly higher risk of subse...
...ing to outer space for help in their attempt to pr...osomiasis in southern China. , Once the Three Gor...use satellite data from space to determine whether...ease that can damage internal organs and impair gr...
...ease the emotional pain of patients who are being ...ssant help to fight cancer itself? , Dr. Dan Peer... at Tel Aviv University is proving that it can. A...sed anti-cancer drug. , "The good news is that t...
Other Medicine News:Health News:Stem cells and leukemia battle for marrow microenvironment 2Health News:Stem cells and leukemia battle for marrow microenvironment 3Health News:Common treatment for men's pelvic pain proves ineffective, Queen's-led study shows 2Health News:Experts Say Blood Sugar Guidelines Remain Effective 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 2Health News:Panic attacks linked to higher risk of heart attacks and heart disease, especially in younger people 3Health News:Watching water from space could aid disease prevention in China 2Health News:Watching water from space could aid disease prevention in China 3Health News:Not just for depression anymore 2(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-As...the "Company") (NYSE: SCR ), a leading pharmaceu...ufacturing, and marketing of branded,generic and p...d that its,subsidiary Jiangsu Yanshen Biological T...suspended production of all its products in order ...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewswir...uding a late-breaking presentation on Tasigna®... myeloid leukemia, demonstrate the strength of the...are of patients. ,, The new data, at the 51st ...g and Exposition, highlight the company,s current ...
(Date:12/1/2009)..., TEMECULA, Calif., Dec. 1 /PRNewswire-FirstCal...tin Board: PSTX) announced today that it has appoi...ef Financial Officer, Treasurer and Corporate Secr...CFO since 2008. Prior to joining Patient Safety T...ance, Chief Financial Officer, Treasurer and Corpo...
Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 1Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 2BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 1BioSpecifics Technologies Corp Added to Russell 3000 and Russell 2000 Indexes 12832 2Depression Anxiety Bad for the Heart 50336 1Depression Anxiety Bad for the Heart 50336 2Depression Anxiety Bad for the Heart 50336 3...nference Call to Discuss Results On Thursday, Marc... March 27, 2007 (PRIME NEWSWIRE) -- MediciNova, In...raded on the Nasdaq,Global Market (Nasdaq:MNOV) an...ange (Code Number:4875), today announced positive,... a Phase II,clinical trial of MN-166 that measures...
...RYTOWN, N.Y. & LEVERKUSEN, Germany--(BUSINESS ...nc. (Nasdaq: REGN) and Bayer,HealthCare AG (NYSE: ...m a pre-planned interim analysis of a Phase 2 rand...th the neovascular form of,age-related macular deg...mary endpoint of a statistically significant reduc...
Other Medicine Technology:MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 2MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 3MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 4MediciNova Announces Positive Clinical Results From MN-166 Phase II,Multiple Sclerosis Trial 5Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in,Age-Related Macular Degeneration 2Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in,Age-Related Macular Degeneration 3Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in,Age-Related Macular Degeneration 4Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in,Age-Related Macular Degeneration 5CKX41 Inverted Laboratory System Microscope
Eclipse TE2000U
IX71 Inverted Research Microscope
...clipse TS-100 is an innovative and efficient inver...plements any research facility. , ,Outstanding Op...harp images in all magnifications. Objectives deli...n and contrast, chromatic aberration free correcti...
Medicine Products: